MRK
27
-3
BIIB
30
-9
WAT
61
-3
MMC
61
-3
EXC
37
2
WBA
53
6
COF
68
3
CAT
64
2
AZO
58
5
DOV
71
2
PM
54
-2
UPS
41
-4
MCD
62
2
NWSA
78
-19
CRM
75
8
SYK
66
2
MSFT
51
-4
LNC
50
5
LRCX
49
-3
COST
63
-4
MRK
27
-3
BIIB
30
-9
WAT
61
-3
MMC
61
-3
EXC
37
2
WBA
53
6
COF
68
3
CAT
64
2
AZO
58
5
DOV
71
2
PM
54
-2
UPS
41
-4
MCD
62
2
NWSA
78
-19
CRM
75
8
SYK
66
2
MSFT
51
-4
LNC
50
5
LRCX
49
-3
COST
63
-4
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
86

CORT
Corcept Therapeutics

Last Price:
57.76
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Corcept Therapeutics Price Quote

$57.76
-1.36 (-2.3%)
(Updated: November 12, 2024 at 5:55 PM ET)

Corcept Therapeutics Key Stats

Buy
86
Corcept Therapeutics (CORT) is a Buy
Day range:
$58.02 - $60.05
52-week range:
$20.84 - $61.66
Dividend yield:
0%
P/E ratio:
62.89
P/S ratio:
10.48
P/B ratio:
9.7%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
136.2%
Market cap:
$6.2B
Revenue:
$482.4M
EPS:
$1.26

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.46%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $144.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$23M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$96.1M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 25.77%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 21.04%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 25.77%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 46.43% 41.38%
Revenue: 47.69% 6.15%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.90
Upside from Last Price: 26.69%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    132.6M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders